Drug: TENOFOVIR Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 34 Number of Pages: 2
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
38397925 | TENOFOVIR | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 DY | F | 3 KG | 20160825 | US |
63335564 | TENOFOVIR | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 DY | M | 3 KG | 20160822 | AR |
94991263 | TENOFOVIR | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 1.00 DY | 2 KG | 20160720 | US | |
94991303 | TENOFOVIR | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 1.00 DY | 1 KG | 20160720 | US | |
97053604 | TENOFOVIR | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | 0 | 20160824 | IT | |
97054513 | TENOFOVIR | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 1.00 DY | M | 0 | 20160720 | IT |
102887253 | TENOFOVIR | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | M | 3 KG | 20160824 | IT |
119535702 | TENOFOVIR | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 15.00 MON | M | 3 KG | 20160721 | PT |
125858731 | Tenofovir | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160725 | US | |
126874891 | Tenofovir | Foetal exposure during pregnancy | RANBAXY | 0.00 | 0 | 20160826 | CH | |
127304231 | TENOFOVIR | Foetal exposure during pregnancy | ABBVIE | 0.00 | 0 | 20160909 | COUNTRY NOT SPECIFIED | |
127304271 | TENOFOVIR | Foetal exposure during pregnancy | ABBVIE | 0.00 | 0 | 20160909 | COUNTRY NOT SPECIFIED | |
127304371 | TENOFOVIR | Foetal exposure during pregnancy | ABBVIE | 0.00 | 0 | 20160909 | COUNTRY NOT SPECIFIED | |
127428941 | TENOFOVIR | Foetal exposure during pregnancy | MYLAN | 0.00 | 0 | 20160914 | MZ | |
127447631 | Tenofovir | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160915 | US | |
127447641 | Tenofovir | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160915 | US | |
127447691 | Tenofovir | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160915 | US | |
127447831 | Tenofovir | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160915 | US | |
127450741 | Tenofovir | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160915 | US | |
127676692 | TENOFOVIR | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 | F | 1 KG | 20160926 | MZ |
Total Records: 34 Number of Pages: 2